Novavax (NVAX) Misses Q2 EPS by $1.12
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $10.83 --0%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
NEOV, MANU, CTAS, More
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
NEOV, MANU, CTAS, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q2 EPS of ($4.75), $1.12 worse than the analyst estimate of ($3.63). Revenue for the quarter came in at $298 million versus the consensus estimate of $387.87 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Bernstein SocGen Group Starts Amphenol (APH) at Outperform
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
